With respect to the gene expression analysis performed retrospectively incorporating information derived from both clinicopathological characteristics and tumor location, the diagnostic performance of the top genes (ADH1B and FABP4) revealed a stable discriminatory power between both cancers, thereby suggesting that both diseases follow different genetic pathways. The gene discussed is ADH1B; the disease is cancer.